Metfin 500
Metfin 500 is a medicine authorised by Swissmedic under authorisation number 55351. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 08 August 2000 and the authorisation is valid without a time limit. ATC code A10BA02 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 55351 |
|---|---|
| Name | Metfin 500 |
| Full name | Metfin 500, Filmtabletten |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BA02 |
| First authorisation | 08 August 2000 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Metfin 500, Filmtabletten | B | 08 August 2000 |
| 2 | Metfin 850, Filmtabletten | B | 08 August 2000 |
| 3 | Metfin 1000, Filmtabletten | B | 17 June 2004 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 50 | Tablette(n) | A10BA02 | 07.06.2. | B |
| 2 | 30 | Tablette(n) | A10BA02 | 07.06.2. | B |
| 3 | 100 | Tablette(n) | A10BA02 | 07.06.2. | B |
| 4 | 60 | Tablette(n) | A10BA02 | 07.06.2. | B |
| 5 | 120 | Tablette(n) | A10BA02 | 07.06.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Metfin 500 authorised in Switzerland?
Yes. Metfin 500 is authorised by Swissmedic under authorisation number 55351, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Metfin 500 have?
Metfin 500 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Metfin 500?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.